홈 › 전립선암 › 캘리포니아 › San Francisco
CA San Francisco의 전립선암 임상 시험
전립선암 관련 연구 45개가 San Francisco 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
피험자 모집 중3상
- Kaiser Permanente-San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
피험자 모집 중
- Kaiser Permanente-San Francisco, San Francisco
Precision-Based Genomics in Prostate Cancer
피험자 모집 중관찰 연구
- University of California San Francisco, San Francisco
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
피험자 모집 중3상
- San Francisco VA Health Care System ( Site 0093), San Francisco
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
피험자 모집 중3상
- University of California San Francisco, San Francisco
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
피험자 모집 중
- University of California San Francisco, San Francisco
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
피험자 모집 중3상
- Kaiser Permanente-San Francisco, San Francisco
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
피험자 모집 중2상
- University of California, San Francisco, San Francisco
Prostate Active Surveillance Study
피험자 모집 중관찰 연구
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study of Tarlatamab for People With Prostate Cancer
피험자 모집 중2상
- University of California San Francisco, San Francisco
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
피험자 모집 중1상
- University of California, San Francisco, San Francisco
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
피험자 모집 중관찰 연구
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
피험자 모집 중3상
- Research Site, San Francisco
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
피험자 모집 중1상
- University of California San Francisco, San Francisco
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
피험자 모집 중2상
- University of California San Francisco, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
피험자 모집 중1상
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
피험자 모집 중1/2상
- Research Site, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- University of California San Francisco Cancer Center, San Francisco
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
피험자 모집 중1상
- University of California San Francisco, San Francisco
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
피험자 모집 중1/2상
- University of California, San Francisco, San Francisco
PSMA PET Combined With MRI for the Detection of PCa
피험자 모집 중3상건강한 지원자 환영
- University of California San Francisco, San Francisco
Imaging of Solid Tumors Using 18F-TRX
피험자 모집 중1상
- University of California, San Francisco, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
피험자 모집 중1상
- University of California San Francisco, San Francisco
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
피험자 모집 중관찰 연구
- University of California, San Francisco, San Francisco
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
피험자 모집 중2상
- University of California San Francisco, San Francisco
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
피험자 모집 중1상
- University of California San Francisco, San Francisco
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
피험자 모집 중2상
- University of California, San Francisco, San Francisco
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
피험자 모집 중1상
- University of California, San Francisco, San Francisco
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
피험자 모집 중2상
- University of California, San Francisco, San Francisco
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
피험자 모집 중관찰 연구건강한 지원자 환영
- University of California, San Francisco, San Francisco
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
피험자 모집 중
- UCSF, San Francisco
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
피험자 모집 중초기 1상
- University of California, San Francisco, San Francisco
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
피험자 모집 중
- University of California, San Francisco
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
피험자 모집 중3상
- Kaiser Permanente-San Francisco, San Francisco
Mechanisms of Resistance to PSMA Radioligand Therapy
피험자 모집 중관찰 연구
- University of California, San Francisco, San Francisco
64Cu-GRIP B in Patients With Advanced Malignancies
피험자 모집 중1/2상
- University of California, San Francisco, San Francisco
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
피험자 모집 중
- San Francisco Veterans Affairs Medical Center, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
피험자 모집 중1/2상
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
피험자 모집 중1상
- University of California San Francisco, San Francisco
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
피험자 모집 중2상
- University of California, San Francisco, San Francisco
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
피험자 모집 중
- Zuckerberg San Francisco General Hospital, San Francisco
- San Francisco Veterans Administration Medical Center, San Francisco
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, San Francisco
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
피험자 모집 중3상
- Kaiser Permanente-San Francisco, San Francisco
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
피험자 모집 중관찰 연구
- University of California, San Francisco, San Francisco
다른 도시의 전립선암 시험
- New York City, NY연구 103개
- Houston, TX연구 76개
- Los Angeles, CA연구 61개
- Boston, MA연구 59개
- St. Louis, MO연구 46개
- Chicago, IL연구 45개
- Philadelphia, PA연구 44개
- Baltimore, MD연구 43개
- Nashville, TN연구 42개
- Seattle, WA연구 42개
- Washington, DC연구 38개
- Dallas, TX연구 36개
San Francisco의 다른 연구
- 유방암연구 43개
- 비소세포폐암연구 36개
- 암 (전체)연구 35개
- 심부전연구 29개
- 전이성 암연구 28개
- 폐암연구 23개
- 흑색종연구 22개
- 췌장암연구 20개
- 난소암연구 19개
- 대장직장암연구 18개
- 심혈관 질환연구 18개
- 교모세포종연구 17개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.